{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T17:02:30Z","timestamp":1773766950167,"version":"3.50.1"},"reference-count":20,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2009,3,26]],"date-time":"2009-03-26T00:00:00Z","timestamp":1238025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2009,8]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>The aim of the study was to determine whether immune reconstitution inflammatory syndrome (IRIS) associated with herpes zoster occurs on a different time frame from other instances of IRIS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Statistical analysis of onset times of herpes zoster\u2010associated IRIS and other cases of IRIS was carried out in a retrospective cohort starting antiretroviral therapy at advanced stages of HIV infection.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Herpes zoster\u2010associated IRIS was significantly more frequent after the first 3 months of successful highly active antiretroviral therapy (HAART), than other instances of IRIS (IRIS associated with tuberculosis, <jats:italic>Mycobacterium avium<\/jats:italic> complex, Kaposi's sarcoma, etc.) which mainly occurred during the first 3 months of treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The characteristic onset time pattern of herpes zoster\u2010associated IRIS, coincident with the second phase of immune recovery under HAART, suggests that the immune recovery events underlying herpes zoster\u2010associated IRIS are different from those underlying other types of IRIS. Our findings may be useful in improving the follow\u2010up of individuals who start HAART at an advanced stage of HIV infection.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1468-1293.2009.00700.x","type":"journal-article","created":{"date-parts":[[2009,3,27]],"date-time":"2009-03-27T02:51:12Z","timestamp":1238122272000},"page":"454-457","source":"Crossref","is-referenced-by-count":14,"title":["Later onset of herpes zoster\u2010associated immune reconstitution inflammatory syndrome"],"prefix":"10.1111","volume":"10","author":[{"given":"E","family":"Espinosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1","family":"Pe\u00f1a\u2010Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CE","family":"Ormsby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Vega\u2010Barrientos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Reyes\u2010Ter\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,7,8]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"266","article-title":"Immune restoration inflammatory syndromes","volume":"5","author":"Stoll M","year":"2003","journal-title":"the dark side of successful antiretroviral treatment"},{"key":"e_1_2_6_3_2","first-page":"9","article-title":"Immune reconstitution inflammatory syndrome (IRIS)","volume":"4","author":"Murdoch DM","year":"2007","journal-title":"review of common infectious manifestations and treatment options"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(01)00703-3"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1086\/515019"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1293.2000.00012.x"},{"key":"e_1_2_6_7_2","first-page":"213","article-title":"Immune reconstitution inflammatory syndrome","volume":"81","author":"Shelburne SA","year":"2002","journal-title":"emergence of a unique syndrome during highly active antiretroviral therapy"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1086\/499356"},{"key":"e_1_2_6_9_2","first-page":"456","article-title":"Immune reconstitution inflammatory syndrome","volume":"46","author":"Manabe YC","year":"2007","journal-title":"risk factors and treatment implications"},{"key":"e_1_2_6_10_2","unstructured":"Panel on Antiretroviral Guidelines for Adult and Adolescents.2008. Guidelines for the use of antiretroviral agents in HIV\u20101\u2010infected adults and adolescents. Washington DC: Department of Health and Human Services November 3 2008; 1\u2013139. Available athttp:\/\/www.aidsinfo.nih.gov\/ContentFiles\/AdultandAdolescentGL.pdfaccessed December 15 2008."},{"key":"e_1_2_6_11_2","unstructured":"R Development Core Team.R:A Language and Enviroment for Statistical Computing. Vienna: R Foundation for Statistical Computing 2008."},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1293.2000.00012.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2007.10.006"},{"key":"e_1_2_6_14_2","first-page":"601","article-title":"Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa","volume":"22","author":"Murdoch DM","year":"2008","journal-title":"a prospective study"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1086\/499356"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.277.5322.112"},{"issue":"3","key":"e_1_2_6_17_2","first-page":"3","article-title":"Effects of antiretroviral therapy on immune reconstitution","volume":"4","author":"Autran B.","year":"1999","journal-title":"Antivir Ther"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200102002-00003"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1086\/428618"},{"key":"e_1_2_6_20_2","first-page":"601","article-title":"Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa","volume":"22","author":"Murdoch DM","year":"2008","journal-title":"a prospective study"},{"key":"e_1_2_6_21_2","first-page":"335","article-title":"Tuberculosis\u2010associated immune reconstitution disease","volume":"21","author":"Lawn SD","year":"2007","journal-title":"incidence, risk factors and impact in an antiretroviral treatment service in South Africa"}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1293.2009.00700.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-1293.2009.00700.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T15:52:15Z","timestamp":1696866735000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1293.2009.00700.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,8]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["10.1111\/j.1468-1293.2009.00700.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-1293.2009.00700.x","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"value":"1464-2662","type":"print"},{"value":"1468-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,8]]}}}